Pricing Log in Create free account

BioLineRx Ltd. (BLRX) vs Kiora Pharmaceuticals, Inc. (KPRX)

BioLineRx Ltd. and Kiora Pharmaceuticals, Inc. are both Biotechnology companies. BioLineRx Ltd. and Kiora Pharmaceuticals, Inc. are of similar size ($10.7M and $10.2M). Kiora Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 983.7% against −91.9%. Kiora Pharmaceuticals, Inc. has the higher net margin (0.00% vs −502.1%) and the lower return on invested capital (−44,053.9% vs −74.3%). Across the 17 metrics below, Kiora Pharmaceuticals, Inc. leads on 10 and BioLineRx Ltd. on 7.

Valuation

Metric BLRX KPRX Biotechnology median
P/E n/m n/m 8.50
P/S 6.51 0.79 9.71
P/B 0.55 0.88 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.15 0.64
EV/Sales 1.93 (0.10) 9.21
Earnings yield (82.84%) (103.07%) (33.15%)
Free cash flow yield (119.61%) (58.10%) (25.50%)

Profitability

Metric BLRX KPRX Biotechnology median
Gross margin 80.03% 85.06% 65.16%
Operating margin (874.28%) 0.00% 0.00%
Net margin (502.08%) 0.00% 0.00%
Free cash flow margin (776.29%) 0.00% 0.00%
Return on equity (38.10%) (56.36%) (56.36%)
Return on assets (18.21%) (39.43%) (48.04%)
Return on invested capital (74.28%) (44,053.91%) 0.00%

Growth

Metric BLRX KPRX Biotechnology median
Revenue growth (TTM) (91.93%) 983.73% 6.02%
EPS growth (last fiscal year) 93.72% (403.45%) 30.26%
Revenue growth, 5-year CAGR — 88.72% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BLRX KPRX Biotechnology median
Debt to equity 0.40 0.00 0.00
Current ratio 1.20 8.97 4.72
Net debt to EBITDA 1.22 1.33 0.96

Dividend

Metric BLRX KPRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BLRX KPRX Biotechnology median
Market cap 10.21m 10.66m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack